Welcome to industryreportstore.com

Need help? +44(0)20 7936 6830

Biosimilars market research, reports and industry analysis

mail

Contact us for professional industry advice

Email us or call

+44(0)20 7936 6830
mail

for FREE research alerts
to your inbox

7 Item(s)

Page 1 of 1

  1. Global mAb Biosimilars Market 2016-2020

    By: Technavio
    , Published: Sep-2016
    , Product code: IRTNTR10349
    The report covers the present scenario and the growth prospects of the global monoclonal antibody (mAb) biosimilars market 2016-2020. To calculate the market size, the report considers the report considers the revenue generated from the sales of mAbs. The report also considers the revenues generated from the sales of drugs that are expected to be launched during the forecast period.
    $2,500.00

  2. Global Biosimilars Market 2016-2020

    By: Technavio
    , Published: Aug-2016
    , Product code: IRTNTR10077
    The report covers the present scenario and the growth prospects of the global biosimilars market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of products such as somatropin, erythropoietin, colony-stimulating factors (CSF), interferons, interleukins, insulin and insulin analogs, follicle stimulating hormones (FSH), monoclonal antibodies (mAbs), and low molecular weight heparins (LMWH).
    $2,500.00

  3. Global Biosimulation Market Insights, Opportunity Analysis, Market Shares and Forecast 2016 – 2022

    By: Occams Research
    , Published: Apr-2016
    , Product code: HAD-1261015
    Biosimulation is explained as a computer-aided mathematical simulation of biological processes and systems and hence is an integral part of systems biology. The main aim of Biosimulation is model-based prediction of the behavior and the dynamics of biological systems e.g. the response of an organ or a single cell towards a chemical. It is a predictive tool and used in discovery stage to determine the future outcomes of current experimental trials.
    $3,900.00

  4. Global Oncology Biosimilars Market 2016-2020

    By: Technavio
    , Published: Feb-2016
    , Product code: IRTNTR8749
    The report covers the present scenario and the growth prospects of the global oncology biosimilars market for the period 2016-2020. To calculate the market size, the report considers revenue generated from the sales of biosimilars used to treat cancer.
    $3,000.00

  5. Latest Chinese Guidance for Development, Evaluation, License Approval of Biosimilars

    By: Access China Management Consulting Ltd
    , Published: May-2015
    , Product code: ACMC201505008
    Responding to strong desire of overseas and multinational pharmaceutical manufacturers and domestic pharmaceutical manufacturers to carry out research and development of biosimilar products, this is first time in history, Chinese pharmaceutical authorities, China Food and Drug Administration officially issued a technical guidance for development and evaluation of biosimilars and defined the pathway of license approval for biosimilars. Chinese pharmaceutical authorities require that when conducting the research and development of biosimilar products in China, the applicant of biosimilar registration application and its sponsor should be in compliance with the Guidance and follow the pathway of license approval of biosimilars.
    $750.00

  6. Global Biosimilars Market 2014-2018

    By: Technavio
    , Published: Feb-2014
    , Product code: IRTNTR3323-
    TechNavio's analysts forecast the Global Biosimilars Market to grow at a CAGR of 27.58 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing number of patent expirations. The Global Biosimilars Market has also been witnessing the outsourcing of biosimilar manufacturing. However, the risks related to drug failure could pose a challenge to the growth of this market.
    $3,000.00

  7. Biosimilars - The Future Transformation of Product Exclusivity in the Biotechnology Arena

    By: CBR Pharma Insights
    , Published: Jun-2009
    , Product code: CBRSV004-
    The nature of biotechnology has, up until recently, prevented the threat of generic intrusion on product sales. Biologics are difficult to replicate compared to small molecules and even slight differences in manufacturing processes could lead to significant clinical differences.
    $3,900.00

7 Item(s)

Page 1 of 1